Antioxidant potential of CORM-A1 and resveratrol during TNF-α/cycloheximide-induced oxidative stress and apoptosis in murine intestinal epithelial MODE-K cells

Toxicology and Applied Pharmacology

Volumn 288, Issue 2, 2015, Pages 161-178

  Babu, Dinesh ^a   Leclercq, Georges ^b   Goossens, Vera ^b,c   Remijsen, Quinten ^b,c   Vandenabeele, Peter ^b,c   Motterlini, Roberto ^d   Lefebvre, Romain A ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d FACULTÉ DE MÉDECINE   (France)

Author keywords

CORM A1; Intestinal epithelial cells; Mitochondria; NADPH oxidase; Resveratrol; TNF CHX

Indexed keywords

ANTIMYCIN A1; ANTIOXIDANT; CARBON MONOXIDE RELEASING MOLECULE; CORM A 1; CYCLOHEXIMIDE; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; RESVERATROL; ROTENONE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; BORANE DERIVATIVE; CARBONIC ACID DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SODIUM BORANOCARBONATE; STILBENE DERIVATIVE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL LEVEL; CELL PROTECTION; CELLULAR OXYGEN CONSUMPTION; CONTROLLED STUDY; DRUG MECHANISM; INTESTINE EPITHELIUM CELL; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL FUNCTION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; ANIMAL; CELL LINE; COMPARATIVE STUDY; DRUG EFFECTS; EPITHELIUM CELL; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; PATHOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APOPTOSIS; BORANES; CARBONATES; CELL LINE; CYCLOHEXIMIDE; CYTOPROTECTION; EPITHELIAL CELLS; INTESTINAL MUCOSA; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA; NADPH OXIDASE; OXIDATIVE STRESS; OXYGEN CONSUMPTION; STILBENES; SUPEROXIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84942297525     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2015.07.007     Document Type: Article

References (83)

1. Aghdassi E., Wendland B.E., Steinhart A.H., Wolman S.L., Jeejeebhoy K., Allard J.P. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. A randomized controlled trial. Am. J. Gastroenterol. 2003, 98:348-353.
2. Ahmad K.A., Clement M.V., Pervaiz S. Pro-oxidant activity of low doses of resveratrol inhibits hydrogen peroxide-induced apoptosis. Ann. N. Y. Acad. Sci. 2003, 1010:365-373.
3. Ahn B.O., Ko K.H., Oh T.Y., Cho H., Kim W.B., Lee K.J., Cho S.W., Hahm K.B. Efficacy of use of colonoscopy in dextran sulfate sodium induced ulcerative colitis in rats: the evaluation of the effects of antioxidant by colonoscopy. Int. J. Colorectal Dis. 2001, 16:174-181.
4. Almeida A.S., Figueiredo-Pereira C., Vieira H.L. Carbon monoxide and mitochondria-modulation of cell metabolism, redox response and cell death. Front. Physiol. 2015, 6:33.
5. Anup R., Aparna V., Pulimood A., Balasubramanian K.A. Surgical stress and the small intestine: role of oxygen free radicals. Surgery 1999, 125:560-569.
6. Babu D., Soenen S.J., Raemdonck K., Leclercq G., De Backer O., Motterlini R., Lefebvre R.A. TNF-alpha/cycloheximide-induced oxidative stress and apoptosis in murine intestinal epithelial MODE-K cells. Curr. Pharm. Des. 2012, 18:4414-4425.
7. Babu D., Motterlini R., Lefebvre R.A. CO and CO-releasing molecules (CO-RMs) in acute gastrointestinal inflammation. Br. J. Pharmacol. 2014, 172:1557-1573.
8. Babu D., Leclercq G., Goossens V., Vanden Berghe T., Van Hamme E., Vandenabeele P., Lefebvre R.A. Mitochondria and NADPH oxidases are the major sources of TNF-alpha/cycloheximide-induced oxidative stress in murine intestinal epithelial MODE-K cells. Cell. Signal. 2015, 27:1141-1158.
9. Barbosa D.S., Cecchini R., El Kadri M.Z., Rodriguez M.A., Burini R.C., Dichi I. Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids. Nutrition 2003, 19:837-842.
10. Baregamian N., Song J., Bailey C.E., Papaconstantinou J., Evers B.M., Chung D.H. Tumor necrosis factor-alpha and apoptosis signal-regulating kinase 1 control reactive oxygen species release, mitochondrial autophagy, and c-Jun N-terminal kinase/p38 phosphorylation during necrotizing enterocolitis. Oxid. Med. Cell. Longev. 2009, 2:297-306.
11. Basu Ball W., Kar S., Mukherjee M., Chande A.G., Mukhopadhyaya R., Das P.K. Uncoupling protein 2 negatively regulates mitochondrial reactive oxygen species generation and induces phosphatase-mediated anti-inflammatory response in experimental visceral leishmaniasis. J. Immunol. 2011, 187:1322-1332.
12. Basuroy S., Bhattacharya S., Leffler C.W., Parfenova H. Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells. Am. J. Physiol. Cell Physiol. 2009, 296:C422-C432.
13. Basuroy S., Tcheranova D., Bhattacharya S., Leffler C.W., Parfenova H. Nox4 NADPH oxidase-derived reactive oxygen species, via endogenous carbon monoxide, promote survival of brain endothelial cells during TNF-alpha-induced apoptosis. Am. J. Physiol. Cell Physiol. 2011, 300:C256-C265.
14. Bell R.M., Cave A.C., Johar S., Hearse D.J., Shah A.M., Shattock M.J. Pivotal role of NOX-2-containing NADPH oxidase in early ischemic preconditioning. FASEB J. 2005, 19:2037-2039.
15. Bereswill S., Munoz M., Fischer A., Plickert R., Haag L.M., Otto B., Kuhl A.A., Loddenkemper C., Gobel U.B., Heimesaat M.M. Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS ONE 2010, 5:e15099.
16. Bilban M., Bach F.H., Otterbein S.L., Ifedigbo E., d'Avila J.C., Esterbauer H., Chin B.Y., Usheva A., Robson S.C., Wagner O., Otterbein L.E. Carbon monoxide orchestrates a protective response through PPARgamma. Immunity 2006, 24:601-610.
17. Bilban M., Haschemi A., Wegiel B., Chin B.Y., Wagner O., Otterbein L.E. Heme oxygenase and carbon monoxide initiate homeostatic signaling. J. Mol. Med. 2008, 86:267-279.
18. Brar S.S., Kennedy T.P., Sturrock A.B., Huecksteadt T.P., Quinn M.T., Murphy T.M., Chitano P., Hoidal J.R. NADPH oxidase promotes NF-kappaB activation and proliferation in human airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 282:L782-L795.
19. Cetinkaya A., Bulbuloglu E., Kurutas E.B., Ciralik H., Kantarceken B., Buyukbese M.A. Beneficial effects of N-acetylcysteine on acetic acid-induced colitis in rats. Tohoku J. Exp. Med. 2005, 206:131-139.
20. Chen Q., Vazquez E.J., Moghaddas S., Hoppel C.L., Lesnefsky E.J. Production of reactive oxygen species by mitochondria: central role of complex III. J. Biol. Chem. 2003, 278:36027-36031.
21. Chin B.Y., Jiang G., Wegiel B., Wang H.J., Macdonald T., Zhang X.C., Gallo D., Cszimadia E., Bach F.H., Lee P.J., Otterbein L.E. Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:5109-5114.
22. Coant N., Ben Mkaddem S., Pedruzzi E., Guichard C., Treton X., Ducroc R., Freund J.N., Cazals-Hatem D., Bouhnik Y., Woerther P.L., Skurnik D., Grodet A., Fay M., Biard D., Lesuffleur T., Deffert C., Moreau R., Groyer A., Krause K.H., Daniel F., Ogier-Denis E. NADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colon. Mol. Cell. Biol. 2010, 30:2636-2650.
23. Csiszar A., Sosnowska D., Wang M., Lakatta E.G., Sonntag W.E., Ungvari Z. Age-associated proinflammatory secretory phenotype in vascular smooth muscle cells from the non-human primate Macaca mulatta: reversal by resveratrol treatment. J. Gerontol. A Biol. Sci. Med. Sci. 2012, 67:811-820.
24. Damiani C.R., Benetton C.A., Stoffel C., Bardini K.C., Cardoso V.H., Di Giunta G., Pinho R.A., Dal-Pizzol F., Streck E.L. Oxidative stress and metabolism in animal model of colitis induced by dextran sulfate sodium. J. Gastroenterol. Hepatol. 2007, 22:1846-1851.
25. D'Amico G., Lam F., Hagen T., Moncada S. Inhibition of cellular respiration by endogenously produced carbon monoxide. J. Cell Sci. 2006, 119:2291-2298.
26. De Backer O., Elinck E., Blanckaert B., Leybaert L., Motterlini R., Lefebvre R.A. Water-soluble CO-releasing molecules reduce the development of postoperative ileus via modulation of MAPK/HO-1 signalling and reduction of oxidative stress. Gut 2009, 58:347-356.
27. de la Lastral C.A., Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem. Soc. Trans. 2007, 35:1156-1160.
28. de Winter B.Y., van Nassauw L., de Man J.G., de Jonge F., Bredenoord A.J., Seerden T.C., Herman A.G., Timmermans J.P., Pelckmans P.A. Role of oxidative stress in the pathogenesis of septic ileus in mice. Neurogastroenterol. Motil. 2005, 17:251-261.
29. Duprez L., Takahashi N., Van Hauwermeiren F., Vandendriessche B., Goossens V., Vanden Berghe T., Declercq W., Libert C., Cauwels A., Vandenabeele P. RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 2011, 35:908-918.
30. Foresti R., Motterlini R. Interaction of carbon monoxide with transition metals: evolutionary insights into drug target discovery. Curr. Drug Targets 2010, 11:1595-1604.
31. Foti Cuzzola V., Ciurleo R., Giacoppo S., Marino S., Bramanti P. Role of resveratrol and its analogues in the treatment of neurodegenerative diseases: focus on recent discoveries. CNS Neurol. Disord. Drug Targets 2011, 10:849-862.
32. Frasier C.R., Moukdar F., Patel H.D., Sloan R.C., Stewart L.M., Alleman R.J., La Favor J.D., Brown D.A. Redox-dependent increases in glutathione reductase and exercise preconditioning: role of NADPH oxidase and mitochondria. Cardiovasc. Res. 2013, 98:47-55.
33. Fukui M., Choi H.J., Zhu B.T. Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. Free Radic. Biol. Med. 2010, 49:800-813.
34. Guan Y., Worrell R.T., Pritts T.A., Montrose M.H. Intestinal ischemia-reperfusion injury: reversible and irreversible damage imaged in vivo. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 297:G187-G196.
35. Han D., Canali R., Rettori D., Kaplowitz N. Effect of glutathione depletion on sites and topology of superoxide and hydrogen peroxide production in mitochondria. Mol. Pharmacol. 2003, 64:1136-1144.
36. Holtmann M.H., Schutz M., Galle P.R., Neurath M.F. Functional relevance of soluble TNF-alpha, transmembrane TNF-alpha and TNF-signal transduction in gastrointestinal diseases with special reference to inflammatory bowel diseases. Z. Gastroenterol. 2002, 40:587-600.
37. Jiang F., Zhang Y., Dusting G.J. NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair. Pharmacol. Rev. 2011, 63:218-242.
38. Jin S., Ray R.M., Johnson L.R. TNF-alpha/cycloheximide-induced apoptosis in intestinal epithelial cells requires Rac1-regulated reactive oxygen species. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294:G928-G937.
39. Jones R.M., Luo L., Ardita C.S., Richardson A.N., Kwon Y.M., Mercante J.W., Alam A., Gates C.L., Wu H., Swanson P.A., Lambeth J.D., Denning P.W., Neish A.S. Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. EMBO J. 2013, 32:3017-3028.
40. Kelsen S., Patel B.J., Parker L.B., Vera T., Rimoldi J.M., Gadepalli R.S., Drummond H.A., Stec D.E. Heme oxygenase attenuates angiotensin II-mediated superoxide production in cultured mouse thick ascending loop of Henle cells. Am. J. Physiol. Renal Physiol. 2008, 295:F1158-F1165.
41. Kim H.S., Loughran P.A., Rao J., Billiar T.R., Zuckerbraun B.S. Carbon monoxide activates NF-kappaB via ROS generation and Akt pathways to protect against cell death of hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 295:G146-G152.
42. Kim Y.J., Kim E.H., Hahm K.B. Oxidative stress in inflammation-based gastrointestinal tract diseases: challenges and opportunities. J. Gastroenterol. Hepatol. 2012, 27:1004-1010.
43. Lo Iacono L., Boczkowski J., Zini R., Salouage I., Berdeaux A., Motterlini R., Morin D. A carbon monoxide-releasing molecule (CORM-3) uncouples mitochondrial respiration and modulates the production of reactive oxygen species. Free Radic. Biol. Med. 2011, 50:1556-1564.
44. Millar A.D., Rampton D.S., Chander C.L., Claxson A.W.D., Blades S., Coumbe A., Panetta J., Morris C.J., Blake D.R. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 1996, 39:407-415.
45. Mittal M., Siddiqui M.R., Tran K., Reddy S.P., Malik A.B. Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal. 2014, 20:1126-1167.
46. Motterlini R., Otterbein L.E. The therapeutic potential of carbon monoxide. Nat. Rev. Drug Discov. 2010, 9:728-743.
47. Motterlini R., Clark J.E., Foresti R., Sarathchandra P., Mann B.E., Green C.J. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ. Res. 2002, 90:E17-E24.
48. Motterlini R., Sawle P., Hammad J., Bains S., Alberto R., Foresti R., Green C.J. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J. 2005, 19:284-286.
49. Motterlini R., Haas B., Foresti R. Emerging concepts on the anti-inflammatory actions of carbon monoxide-releasing molecules (CO-RMs). Med. Gas Res. 2012, 2:28.
50. Nakahira K., Kim H.P., Geng X.H., Nakao A., Wang X., Murase N., Drain P.F., Wang X., Sasidhar M., Nabel E.G., Takahashi T., Lukacs N.W., Ryter S.W., Morita K., Choi A.M. Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J. Exp. Med. 2006, 203:2377-2389.
51. Nishikawa M., Oshitani N., Matsumoto T., Nishigami T., Arakawa T., Inoue M. Accumulation of mitochondrial DNA mutation with colorectal carcinogenesis in ulcerative colitis. Br. J. Cancer 2005, 93:331-337.
52. Oshitani N., Kitano A., Okabe H., Nakamura S., Matsumoto T., Kobayashi K. Location of superoxide anion generation in human colonic mucosa obtained by biopsy. Gut 1993, 34:936-938.
53. Ozkan O.V., Yuzbasioglu M.F., Ciralik H., Kurutas E.B., Yonden Z., Aydin M., Bulbuloglu E., Semerci E., Goksu M., Atli Y., Bakan V., Duran N. Resveratrol, a natural antioxidant, attenuates intestinal ischemia/reperfusion injury in rats. Tohoku J. Exp. Med. 2009, 218:251-258.
54. Pastorelli L., De Salvo C., Mercado J.R., Vecchi M., Pizarro T.T. Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics. Front. Immunol. 2013, 4:280.
55. Plotnikov E.Y., Morosanova M.A., Pevzner I.B., Zorova L.D., Manskikh V.N., Pulkova N.V., Galkina S.I., Skulachev V.P., Zorov D.B. Protective effect of mitochondria-targeted antioxidants in an acute bacterial infection. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:E3100-E3108.
56. Ranjan P., Anathy V., Burch P.M., Weirather K., Lambeth J.D., Heintz N.H. Redox-dependent expression of cyclin D1 and cell proliferation by Nox1 in mouse lung epithelial cells. Antioxid. Redox Signal. 2006, 8:1447-1459.
57. Reddy P.H. Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics. J. Biomed. Biotechnol. 2006, 2006:31372.
58. Reifen R., Nissenkorn A., Matas Z., Bujanover Y. 5-ASA and lycopene decrease the oxidative stress and inflammation induced by iron in rats with colitis. J. Gastroenterol. 2004, 39:514-519.
59. Robinson K.M., Janes M.S., Pehar M., Monette J.S., Ross M.F., Hagen T.M., Murphy M.P., Beckman J.S. Selective fluorescent imaging of superoxide in vivo using ethidium-based probes. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:15038-15043.
60. Rodriguez-Rocha H., Garcia-Garcia A., Pickett C., Li S., Jones J., Chen H., Webb B., Choi J., Zhou Y., Zimmerman M.C., Franco R. Compartmentalized oxidative stress in dopaminergic cell death induced by pesticides and complex I inhibitors: distinct roles of superoxide anion and superoxide dismutases. Free Radic. Biol. Med. 2013, 61:370-383.
61. Rubiolo J.A., Mithieux G., Vega F.V. Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur. J. Pharmacol. 2008, 591:66-72.
62. Ryter S.W., Alam J., Choi A.M. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 2006, 86:583-650.
63. Sawle P., Foresti R., Mann B.E., Johnson T.R., Green C.J., Motterlini R. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br. J. Pharmacol. 2005, 145:800-810.
64. Schilder Y.D.C., Heiss E.H., Schachner D., Ziegler J., Reznicek G., Sorescu D., Dirsch V.M. NADPH oxidases 1 and 4 mediate cellular senescence induced by resveratrol in human endothelial cells. Free Radic. Biol. Med. 2009, 46:1598-1606.
65. Seidner D.L., Lashner B.A., Brzezinski A., Banks P.L., Goldblum J., Fiocchi C., Katz J., Lichtenstein G.R., Anton P.A., Kam L.Y., Garleb K.A., Demichele S.J. An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial. Clin. Gastroenterol. Hepatol. 2005, 3:358-369.
66. Sharma R., Tepas J.J. Microecology, intestinal epithelial barrier and necrotizing enterocolitis. Pediatr. Surg. Int. 2010, 26:11-21.
67. Shin S.M., Cho I.J., Kim S.G. Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3 beta inhibition downstream of poly(ADP-ribose)polymerase-LKB1 pathway. Mol. Pharmacol. 2009, 76:884-895.
68. Snoek S.A., Dhawan S., van Bree S.H., Cailotto C., van Diest S.A., Duarte J.M., Stanisor O.I., Hilbers F.W., Nijhuis L., Koeman A., van den Wijngaard R.M., Zuurbier C.J., Boeckxstaens G.E., de Jonge W.J. Mast cells trigger epithelial barrier dysfunction, bacterial translocation and postoperative ileus in a mouse model. Neurogastroenterol. Motil. 2012, 24(172-184):e191.
69. Srisook K., Han S.S., Choi H.S., Li M.H., Ueda H., Kim C., Cha Y.N. CO from enhanced HO activity or from CORM-2 inhibits both O-2(-) and NO production and downregulates HO-1 expression in LPS-stimulated macrophages. Biochem. Pharmacol. 2006, 71:307-318.
70. St-Pierre J., Buckingham J.A., Roebuck S.J., Brand M.D. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J. Biol. Chem. 2002, 277:44784-44790.
71. Szeto H.H. Cell-permeable, mitochondrial-targeted, peptide antioxidants. AAPS J. 2006, 8:E277-E283.
72. Taille C., El-Benna J., Lanone S., Boczkowski J., Motterlini R. Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J. Biol. Chem. 2005, 280:25350-25360.
73. Tiede L.M., Cook E.A., Morsey B., Fox H.S. Oxygen matters: tissue culture oxygen levels affect mitochondrial function and structure as well as responses to HIV viroproteins. Cell Death Dis. 2011, 2:e246.
74. Ungvari Z., Labinskyy N., Mukhopadhyay P., Pinto J.T., Bagi Z., Ballabh P., Zhang C., Pacher P., Csiszar A. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H1876-H1881.
75. Vasina V., Broccoli M., Ursino M.G., Canistro D., Valgimigli L., Soleti A., Paolini M., De Ponti F. Non-peptidyl low molecular weight radical scavenger IAC attenuates DSS-induced colitis in rats. World J. Gastroenterol. 2010, 16:3642-3650.
76. Vidal K., Grosjean I., evillard J.P., Gespach C., Kaiserlian D. Immortalization of mouse intestinal epithelial cells by the SV40-large T gene. Phenotypic and immune characterization of the MODE-K cell line. J. Immunol. Methods 1993, 166:63-73.
77. Wang X., Wang Y., Kim H.P., Nakahira K., Ryter S.W., Choi A.M. Carbon monoxide protects against hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation. J. Biol. Chem. 2007, 282:1718-1726.
78. Wang H., Yang Y.J., Qian H.Y., Zhang Q., Xu H., Li J.J. Resveratrol in cardiovascular disease: what is known from current research?. Heart Fail. Rev. 2012, 17:437-448.
79. Wang A., Keita A.V., Phan V., McKay C.M., Schoultz I., Lee J., Murphy M.P., Fernando M., Ronaghan N., Balce D., Yates R., Dicay M., Beck P.L., MacNaughton W.K., Soderholm J.D., McKay D.M. Targeting mitochondria-derived reactive oxygen species to reduce epithelial barrier dysfunction and colitis. Am. J. Pathol. 2014, 184:2516-2527.
80. Xu W., Liu L., Charles I.G., Moncada S. Nitric oxide induces coupling of mitochondrial signalling with the endoplasmic reticulum stress response. Nat. Cell Biol. 2004, 6:1129-1134.
81. Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.
82. Zhou X., Chen M., Zeng X., Yang J., Deng H., Yi L., Mi M.T. Resveratrol regulates mitochondrial reactive oxygen species homeostasis through Sirt3 signaling pathway in human vascular endothelial cells. Cell Death Dis. 2014, 5.
83. Zuckerbraun B.S., Chin B.Y., Bilban M., d'Avila J.C., Rao J., Billiar T.R., Otterbein L.E. Carbon monoxide signals via inhibition of cytochrome c oxidase and generation of mitochondrial reactive oxygen species. FASEB J. 2007, 21:1099-1106.